P
Polares Medical
Transcatheter posterior leaflet replacement for mitral regurgitation
About Polares Medical
Polares Medical is a clinical-stage structural heart company developing a transcatheter therapy for patients with mitral regurgitation, a heart valve disease in which the mitral valve does not close properly and blood leaks backward into the left atrium. The company was spun out of Swiss heart valve developer Symetis in 2017 and is headquartered in Lausanne, Switzerland, with US operations in Palo Alto, California.
Its lead product, the MRace Posterior Leaflet Replacement (PLR) system, replaces the posterior leaflet of the mitral valve with a prosthetic leaflet designed to improve coaptation with the patient's native anterior leaflet. This hemi-replacement approach sits between valve repair and full valve replacement, and is intended to treat a broad range of mitral anatomies, including patients with secondary (functional) mitral regurgitation who may be poorly suited to transcatheter edge-to-edge repair.
The system is delivered via catheter, aiming to simplify the procedure compared with open-heart surgery and to preserve future treatment options for the patient. MRace has been implanted in more than 70 patients in early clinical studies, and the company is running clinical programs in Europe, the United States and Australia to generate the evidence needed for regulatory approval.
Polares Medical targets interventional cardiologists, cardiac surgeons and hospital heart teams that treat structural heart disease. As a medical device developer, it plans to commercialize its implant and delivery system through sales to hospitals once regulatory clearance is obtained.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 89.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Surgical Equipment, Tech for Hospitals and Clinics, DT and LS, science-based, Swiss DT MedTech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Mar 2026 | $50M | $200M | Undisclosed | ↗ |
| SERIES BOther financing | Jun 2020 | $40M | $160M | Earlybird Venture Capital · IDO Investments · Longitude Capital · Wellington Partners | — |
Growth signals
Latest recorded traffic for Polares Medical is 100 monthly website visits, up 42.9% over the last three months. Polares Medical's team grew 21.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Polares Medical in the Lausanne ecosystem
The Polares Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Earlybird Venture Capital
Wellington Partners
Endeavour Vision
Decheng Capital
IDO Investments
Longitude Capital
Source: Dealroom Talent Intelligence.
See Polares Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










